For the past several months, teams of scientists at the U.S. Department of Energy’s Lawrence Berkeley National Laboratory (Berkeley Lab) have utilized our world-class research facilities to contribute to the national response to COVID-19, resulting in a wide range of promising research.
Scaling-Up Production of New Tests and Treatments for COVID-19
The Advanced Biofuels and Bioproducts Process Development Unit, or ABPDU, is helping two biotech companies ramp up production of potential COVID-19-fighting technologies so they can be ready to meet global demand. One is a highly accurate, easy-to-use testing platform that is much speedier than current diagnostic methods; and the other is a rapid approach for generating antibodies, which may have the potential to be an effective treatment for COVID-19 infections. Go here for more information on this research.
The COVID-19 research performed at the ABPDU is supported by Caspr Biotech and Swiftscale Biologics. ABPDU is funded by the Department of Energy’s Bioenergy Technologies Office (BETO).